• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习的心脏磁共振成像特征可预测新诊断的肺动脉高压患者的死亡率。

Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension.

作者信息

Alabed Samer, Uthoff Johanna, Zhou Shuo, Garg Pankaj, Dwivedi Krit, Alandejani Faisal, Gosling Rebecca, Schobs Lawrence, Brook Martin, Shahin Yousef, Capener Dave, Johns Christopher S, Wild Jim M, Rothman Alexander M K, van der Geest Rob J, Condliffe Robin, Kiely David G, Lu Haiping, Swift Andrew J

机构信息

Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, UK.

出版信息

Eur Heart J Digit Health. 2022 May 2;3(2):265-275. doi: 10.1093/ehjdh/ztac022. eCollection 2022 Jun.

DOI:10.1093/ehjdh/ztac022
PMID:36713008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9708011/
Abstract

AIMS

Pulmonary arterial hypertension (PAH) is a rare but serious disease associated with high mortality if left untreated. This study aims to assess the prognostic cardiac magnetic resonance (CMR) features in PAH using machine learning.

METHODS AND RESULTS

Seven hundred and twenty-three consecutive treatment-naive PAH patients were identified from the ASPIRE registry; 516 were included in the training, and 207 in the validation cohort. A multilinear principal component analysis (MPCA)-based machine learning approach was used to extract mortality and survival features throughout the cardiac cycle. The features were overlaid on the original imaging using thresholding and clustering of high- and low-risk of mortality prediction values. The 1-year mortality rate in the validation cohort was 10%. Univariable Cox regression analysis of the combined short-axis and four-chamber MPCA-based predictions was statistically significant (hazard ratios: 2.1, 95% CI: 1.3, 3.4, -index = 0.70,  = 0.002). The MPCA features improved the 1-year mortality prediction of REVEAL from -index = 0.71 to 0.76 ( ≤ 0.001). Abnormalities in the end-systolic interventricular septum and end-diastolic left ventricle indicated the highest risk of mortality.

CONCLUSION

The MPCA-based machine learning is an explainable time-resolved approach that allows visualization of prognostic cardiac features throughout the cardiac cycle at the population level, making this approach transparent and clinically interpretable. In addition, the added prognostic value over the REVEAL risk score and CMR volumetric measurements allows for a more accurate prediction of 1-year mortality risk in PAH.

摘要

目的

肺动脉高压(PAH)是一种罕见但严重的疾病,若不治疗,死亡率很高。本研究旨在使用机器学习评估PAH患者的心脏磁共振成像(CMR)预后特征。

方法与结果

从ASPIRE注册研究中连续纳入723例未经治疗的PAH患者;516例纳入训练队列,207例纳入验证队列。采用基于多线性主成分分析(MPCA)的机器学习方法,提取整个心动周期的死亡和生存特征。通过对死亡预测值的高、低风险进行阈值化和聚类,将这些特征叠加在原始图像上。验证队列中的1年死亡率为10%。基于短轴和四腔心MPCA联合预测的单变量Cox回归分析具有统计学意义(风险比:2.1,95%CI:1.3,3.4,-指数=0.70,P=0.002)。MPCA特征将REVEAL模型对1年死亡率的预测能力从-指数=0.71提高到0.76(P≤0.001)。收缩末期室间隔和舒张末期左心室异常提示死亡风险最高。

结论

基于MPCA的机器学习是一种可解释的时间分辨方法,能够在群体水平上可视化整个心动周期的心脏预后特征,使该方法具有透明度和临床可解释性。此外,相对于REVEAL风险评分和CMR容积测量,其增加的预后价值能够更准确地预测PAH患者1年的死亡风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/5699ccaa5e30/ztac022f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/0769baf071d8/ztac022ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/82f8b8cd87e1/ztac022f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/b1ac0de8b857/ztac022f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/01ad213fee40/ztac022f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/38660bc98cb3/ztac022f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/1b08699b7d96/ztac022f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/5699ccaa5e30/ztac022f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/0769baf071d8/ztac022ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/82f8b8cd87e1/ztac022f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/b1ac0de8b857/ztac022f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/01ad213fee40/ztac022f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/38660bc98cb3/ztac022f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/1b08699b7d96/ztac022f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec5b/9708011/5699ccaa5e30/ztac022f6.jpg

相似文献

1
Machine learning cardiac-MRI features predict mortality in newly diagnosed pulmonary arterial hypertension.机器学习的心脏磁共振成像特征可预测新诊断的肺动脉高压患者的死亡率。
Eur Heart J Digit Health. 2022 May 2;3(2):265-275. doi: 10.1093/ehjdh/ztac022. eCollection 2022 Jun.
2
A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis.机器学习心脏磁共振方法提取疾病特征并实现肺动脉高压的自动化诊断。
Eur Heart J Cardiovasc Imaging. 2021 Jan 22;22(2):236-245. doi: 10.1093/ehjci/jeaa001.
3
Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.肺动脉高压危险分层的心脏磁共振成像阈值的确定。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):458-468. doi: 10.1164/rccm.201909-1771OC.
4
Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.心脏磁共振预测肺动脉高压临床恶化和死亡率:系统评价和荟萃分析。
JACC Cardiovasc Imaging. 2021 May;14(5):931-942. doi: 10.1016/j.jcmg.2020.08.013. Epub 2020 Sep 30.
5
Establishing minimally important differences for cardiac MRI end-points in pulmonary arterial hypertension.确立肺动脉高压心脏 MRI 终点的最小有意义差异。
Eur Respir J. 2023 Aug 3;62(2). doi: 10.1183/13993003.02225-2022. Print 2023 Aug.
6
Validation of Artificial Intelligence Cardiac MRI Measurements: Relationship to Heart Catheterization and Mortality Prediction.人工智能心脏 MRI 测量的验证:与心导管检查和死亡率预测的关系。
Radiology. 2022 Oct;305(1):68-79. doi: 10.1148/radiol.212929. Epub 2022 Jun 14.
7
Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease.心脏磁共振成像、计算机断层扫描和超声心动图在评估结缔组织病患者疑似肺动脉高压中的诊断效用比较。
J Rheumatol. 2012 Jun;39(6):1265-74. doi: 10.3899/jrheum.110987. Epub 2012 May 15.
8
Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension.磁共振成像在肺动脉高压患者预后评估中的应用
Am J Respir Crit Care Med. 2017 Jul 15;196(2):228-239. doi: 10.1164/rccm.201611-2365OC.
9
Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.应用 CMR 成像无创估计肺动脉压、流量和阻力:来自 ASPIRE 注册研究的推导和前瞻性验证。
JACC Cardiovasc Imaging. 2013 Oct;6(10):1036-1047. doi: 10.1016/j.jcmg.2013.01.013. Epub 2013 Jun 13.
10
The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension-a long-term retrospective multicenter trial.基于监督和无监督学习的肺动脉高压风险分层和表型组合 - 一项长期回顾性多中心试验。
BMC Pulm Med. 2023 Apr 25;23(1):143. doi: 10.1186/s12890-023-02427-2.

引用本文的文献

1
Artificial Intelligence in Nuclear Cardiac Imaging: Novel Advances, Emerging Techniques, and Recent Clinical Trials.核心脏成像中的人工智能:新进展、新兴技术及近期临床试验
J Clin Med. 2025 Mar 19;14(6):2095. doi: 10.3390/jcm14062095.
2
A Non-Invasive Approach to Pulmonary Hypertension.一种肺动脉高压的非侵入性治疗方法。
J Clin Med. 2025 Feb 22;14(5):1473. doi: 10.3390/jcm14051473.
3
A Comprehensive Review of Artificial Intelligence (AI) Applications in Pulmonary Hypertension (PH).人工智能在肺动脉高压中的应用综述

本文引用的文献

1
Stop Explaining Black Box Machine Learning Models for High Stakes Decisions and Use Interpretable Models Instead.停止为高风险决策解释黑箱机器学习模型,转而使用可解释模型。
Nat Mach Intell. 2019 May;1(5):206-215. doi: 10.1038/s42256-019-0048-x. Epub 2019 May 13.
2
Cardiac Magnetic Resonance in Pulmonary Hypertension-an Update.肺动脉高压的心脏磁共振成像——最新进展
Curr Cardiovasc Imaging Rep. 2020;13(12):30. doi: 10.1007/s12410-020-09550-2. Epub 2020 Nov 7.
3
Cardiac-MRI Predicts Clinical Worsening and Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
Medicina (Kaunas). 2025 Jan 7;61(1):85. doi: 10.3390/medicina61010085.
4
Emerging multimodality imaging techniques for the pulmonary circulation.新兴的肺循环多模态成像技术。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01128-2024. Print 2024 Oct.
5
The Role of Cardiac MRI in Pulmonary Hypertension- Is it Still an Underutilized Tool.心脏磁共振成像在肺动脉高压中的作用——它仍然是一种未被充分利用的工具吗?
Open Respir Med J. 2024 Jun 4;18:e18743064288565. doi: 10.2174/0118743064288565240515115239. eCollection 2024.
6
A review of evaluation approaches for explainable AI with applications in cardiology.用于可解释人工智能并应用于心脏病学的评估方法综述。
Artif Intell Rev. 2024;57(9):240. doi: 10.1007/s10462-024-10852-w. Epub 2024 Aug 9.
7
Revolutionising Acute Cardiac Care With Artificial Intelligence: Opportunities and Challenges.人工智能革新急性心脏护理:机遇与挑战。
Can J Cardiol. 2024 Oct;40(10):1813-1827. doi: 10.1016/j.cjca.2024.06.011. Epub 2024 Jun 18.
8
Outcomes of listing for lung and heart-lung transplantation in pulmonary hypertension: comparative experience in France and the UK.肺动脉高压患者肺移植和心肺移植的登记结果:法国和英国的比较经验。
ERJ Open Res. 2024 Jan 22;10(1). doi: 10.1183/23120541.00521-2023. eCollection 2024 Jan.
9
Adopting artificial intelligence in cardiovascular medicine: a scoping review.采用人工智能在心血管医学中的应用:范围综述。
Hypertens Res. 2024 Mar;47(3):685-699. doi: 10.1038/s41440-023-01469-7. Epub 2023 Oct 31.
10
On the Analyses of Medical Images Using Traditional Machine Learning Techniques and Convolutional Neural Networks.关于使用传统机器学习技术和卷积神经网络对医学图像进行分析
Arch Comput Methods Eng. 2023;30(5):3173-3233. doi: 10.1007/s11831-023-09899-9. Epub 2023 Apr 4.
心脏磁共振预测肺动脉高压临床恶化和死亡率:系统评价和荟萃分析。
JACC Cardiovasc Imaging. 2021 May;14(5):931-942. doi: 10.1016/j.jcmg.2020.08.013. Epub 2020 Sep 30.
4
Maximal Exercise Testing Using the Incremental Shuttle Walking Test Can Be Used to Risk-Stratify Patients with Pulmonary Arterial Hypertension.使用递增式往返步行试验进行最大运动测试可用于对肺动脉高压患者进行风险分层。
Ann Am Thorac Soc. 2021 Jan;18(1):34-43. doi: 10.1513/AnnalsATS.202005-423OC.
5
Artificial Intelligence and Texture Analysis in Cardiac Imaging.人工智能与心脏成像中的纹理分析。
Curr Cardiol Rep. 2020 Sep 10;22(11):131. doi: 10.1007/s11886-020-01402-1.
6
Cardiac MR segmentation based on sequence propagation by deep learning.基于深度学习的序列传播的心脏磁共振分割。
PLoS One. 2020 Apr 9;15(4):e0230415. doi: 10.1371/journal.pone.0230415. eCollection 2020.
7
Deep Learning for Cardiac Image Segmentation: A Review.用于心脏图像分割的深度学习:综述
Front Cardiovasc Med. 2020 Mar 5;7:25. doi: 10.3389/fcvm.2020.00025. eCollection 2020.
8
A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis.机器学习心脏磁共振方法提取疾病特征并实现肺动脉高压的自动化诊断。
Eur Heart J Cardiovasc Imaging. 2021 Jan 22;22(2):236-245. doi: 10.1093/ehjci/jeaa001.
9
Identification of Cardiac Magnetic Resonance Imaging Thresholds for Risk Stratification in Pulmonary Arterial Hypertension.肺动脉高压危险分层的心脏磁共振成像阈值的确定。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):458-468. doi: 10.1164/rccm.201909-1771OC.
10
Impaired Cardiovascular Magnetic Resonance-Derived Rapid Semiautomated Right Atrial Longitudinal Strain Is Associated With Decompensated Hemodynamics in Pulmonary Arterial Hypertension.右心房纵向应变的心血管磁共振衍生的快速半自动测量受损与肺动脉高压失代偿性血流动力学有关。
Circ Cardiovasc Imaging. 2019 May;12(5):e008582. doi: 10.1161/CIRCIMAGING.118.008582.